Risperidone in children with disruptive behavior disorders: A 2-year open-label trial

被引：0
|
作者：
Reyes-Harde, M
Croonenberghs, J
Eerdekens, M
机构：
[1] Univ Antwerp, AZ Middelheim, Ctr Child & Adolescent Psychiat, B-2020 Antwerp, Belgium
[2] Johnson & Johnson Pharmaceut Res & Dev, Beerse, Belgium
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2004年 / 14卷
关键词：
D O I：
10.1016/S0924-977X(04)80315-8
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
下载
收藏
页码：S274 / S274
页数：1
相关论文
共 50 条
  • [1] Treating disruptive behavior disorders with risperidone: A 1-year, open-label safety study in children and adolescents
    Haas, Magali
    Karcher, Keith
    Pandina, Gahan J.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (04) : 337 - 345
  • [2] Risperidone in children with disruptive behavior disorders and subaverage intelligence: A 1-year, open-label study of 504 patients
    Croonenberghs, J
    Fegert, JM
    Findling, RL
    De Smedt, G
    Van Dongen, S
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2005, 44 (01): : 64 - 72
  • [3] Treatment With Paliperidone in Children With Behavior Disorders Previously Treated With Risperidone: An Open-Label Trial
    Martin Fernandez-Mayoralas, Daniel
    Fernandez-Jaen, Alberto
    Munoz-Jareno, Nuria
    Calleja-Perez, Beatriz
    Laura Fernandez-Perrone, Ana
    Lopez Arribas, Sonia
    CLINICAL NEUROPHARMACOLOGY, 2012, 35 (05) : 227 - 230
  • [4] An open-label trial of risperidone in children with autism
    Diler, RS
    Firat, S
    Avci, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2002, 63 (01): : 91 - 102
  • [5] An open-label trial of risperidone augmentation for refractory anxiety disorders
    Simon, NM
    Hoge, EA
    Fischmann, D
    Worthington, JJ
    Christian, KM
    Kinrys, G
    Pollack, MH
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (03) : 381 - 385
  • [6] Open-label, prospective trial of olanzapine in adolescents with subaverage intelligence and disruptive behavior disorders
    Handen, Benjamin L.
    Hardan, Antonio Y.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (08): : 928 - 935
  • [7] One-year open-label trial of risperidone monotherapy in children with bipolar disorder
    Mick, E
    Biederman, J
    BIPOLAR DISORDERS, 2005, 7 : 78 - 78
  • [8] An open-label trial of risperidone in children and adolescents with bipolar disorder
    Biederman, J
    Mick, E
    Wozniak, J
    Aleardi, M
    Spencer, T
    Faraone, SV
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (02) : 311 - 317
  • [9] An Open-Label Trial of Risperidone in Children and Adolescents with Severe Mood Dysregulation
    Krieger, Fernanda Valle
    Pheula, Gabriel Ferreira
    Coelho, Roberta
    Zeni, Thamis
    Tramontina, Silza
    Zeni, Cristian Patrick
    Rohde, Luis Augusto
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2011, 21 (03) : 237 - 243
  • [10] Risperidone in elderly schizophrenic patients - An open-label trial
    Berman, I
    Merson, A
    RachovPavlov, J
    Allan, E
    Davidson, M
    Losonczy, MF
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 1996, 4 (02): : 173 - 179
12345